Jump Financial’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35K | Buy |
+453
| New | +$3.35K | ﹤0.01% | 1730 |
|
|
2024
Q3 | – | Sell |
-3,222
| Closed | -$162K | – | 1939 |
|
|
2024
Q2 | $162K | Buy |
3,222
+2,572
| +396% | +$129K | ﹤0.01% | 1586 |
|
|
2024
Q1 | $72.8K | Buy |
+650
| New | +$72.8K | ﹤0.01% | 1812 |
|
|
2023
Q3 | – | Sell |
-896
| Closed | -$73.7K | – | 2104 |
|
|
2023
Q2 | $73.7K | Buy |
+896
| New | +$73.7K | ﹤0.01% | 1694 |
|
|
2023
Q1 | – | Sell |
-2,585
| Closed | -$379K | – | 1880 |
|
|
2022
Q4 | $379K | Buy |
2,585
+801
| +45% | +$117K | 0.02% | 902 |
|
|
2022
Q3 | $301K | Buy |
+1,784
| New | +$301K | 0.01% | 1148 |
|
|
2022
Q2 | – | Sell |
-2,700
| Closed | -$269K | – | 1864 |
|
|
2022
Q1 | $269K | Sell |
2,700
-216
| -7% | -$21.5K | 0.01% | 1128 |
|
|
2021
Q4 | $453K | Buy |
+2,916
| New | +$453K | 0.03% | 700 |
|
|
2021
Q2 | – | Sell |
-1,013
| Closed | -$409K | – | 1285 |
|
|
2021
Q1 | $409K | Buy |
+1,013
| New | +$409K | 0.04% | 482 |
|